within Pharmacolibrary.Drugs.ATC.J;

model J01GB04
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0013333333333333333,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00016,
    k12             = 6,
    k21             = 6
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01GB04</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Kanamycin is an aminoglycoside antibiotic primarily used to treat serious infections caused by Gram-negative bacteria, including tuberculosis. It was historically used for multidrug-resistant tuberculosis (MDR-TB), but its use has declined due to concerns over nephrotoxicity and ototoxicity, and newer drugs are now preferred. It is still approved and used in some settings for specific resistant infections.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in adult patients with normal renal function following intravenous administration</p><h4>References</h4><ol><li><p>Kruizinga, MD, et al., &amp; Zuiker, RGJA (2020). Pharmacokinetics of intravenous and inhaled salbutamol and tobramycin: An exploratory study to investigate the potential of exhaled breath condensate as a matrix for pharmacokinetic analysis. <i>British journal of clinical pharmacology</i> 86(1) 175–181. DOI:<a href=&quot;https://doi.org/10.1111/bcp.14156&quot;>10.1111/bcp.14156</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31658494/&quot;>https://pubmed.ncbi.nlm.nih.gov/31658494</a></p></li><li><p>Nicolau, D, et al., &amp; Nightingale, CH (1992). Once-daily aminoglycosides. <i>Connecticut medicine</i> 56(10) 561–563. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1458882/&quot;>https://pubmed.ncbi.nlm.nih.gov/1458882</a></p></li><li><p>Wilhelmus, KR, et al., &amp; Osato, MS (1987). Tobramycin in ophthalmology. <i>Survey of ophthalmology</i> 32(2) 111–122. DOI:<a href=&quot;https://doi.org/10.1016/0039-6257(87)90103-2&quot;>10.1016/0039-6257(87)90103-2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3317953/&quot;>https://pubmed.ncbi.nlm.nih.gov/3317953</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01GB04;
